Acute opioid withdrawal on accidental injection of naltrexone

Journal of Paediatrics and Child Health

Volumn 39, Issue 4, 2003, Pages 315-317

  Yeo, M ^a   Campbell, V ^a   Bonomo, Y ^a   Sawyer, S M ^a  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

Intravenous drug use; Naltrexone; Opioid antagonists; Opioid withdrawal

Indexed keywords

BENZODIAZEPINE; CANNABINOID; CLONIDINE; DIAZEPAM; LOPERAMIDE; METOCLOPRAMIDE; NALOXONE; NALTREXONE; OPIATE; OPIATE ANTAGONIST; PARACETAMOL; PROCHLORPERAZINE; RANITIDINE; SCOPOLAMINE BUTYL BROMIDE;

ADOLESCENT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DETOXIFICATION; DISEASE COURSE; DRUG DEPENDENCE; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEALTH CARE PERSONNEL; HUMAN; INTRAVENOUS DRUG ABUSE; PRIORITY JOURNAL; TOXICOLOGY; TREATMENT OUTCOME; URINALYSIS; WITHDRAWAL SYNDROME;

ADOLESCENT; FEMALE; HUMANS; NALTREXONE; NARCOTIC ANTAGONISTS; SUBSTANCE ABUSE, INTRAVENOUS; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 0037793056     PISSN: 10344810     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1754.2003.00143.x     Document Type: Article

References (16)

1. Moon L, Meyer P, Grau J. Australia's Young People: Their Health and Wellbeing. Australian Institute of Health and Welfare, Canberra, 1999.
2. Bell J, Young M, Masterman S, Morris A, Mattick R, Bammer G. A pilot study of naltrexone-accelerated detoxification in opioid dependence. Med. J. Aust. 1999; 171: 26-30.
3. Gonzalez J, Brogden R. Naltrexone. A review of its pharmacokinetic properties and therapeutic efficacy in the management of opioid dependence. Drugs 1988; 35: 192-213.
4. MIMS Online. MIMS Online. [Cited 1 Feb 2003] MIMS Australia, Sydney, 2002. Available from: http://mims.hcn.net.au
5. Riordan CE, Kleber HD. Rapid opiate detoxification with clonidine and naltrexone. Lancet 1980; 5: 1079-80.
6. O'Connor PG, Kosten TR. Rapid and ultrarapid detoxification techniques. JAMA 1998; 279: 229-34.
7. Gaughwin M. First, do no harm: Naltrexone-accelerated detoxification. Med. J. Aust. 1999; 171: 499.
8. Morris BJ, Millan MJ, Herz A. Antagonist induced opioid upregulation: In regionally specific modulation of mu, delta, and kappa binding sites in rat brain revealed by quantitative autoradiography. J. Pharmacol. Exp. Ther. 1988; 247: 729-36.
9. Miotto K, McCann MJ, Rawson RA, Frosch D, Ling W. Overdose suicide attempts and death among a cohort of naltrexone-treated opioid addicts. Drug Alcohol Depend. 1997; 45: 131-5.
10. Galloway G. Heroin withdrawal precipitated by nonmedical use of naltrexone. Am. J. Psych. 1993; 150: 347-8.
11. Quigley MA, Boyce SH. Unintentional rapid opioid detoxification. Emerg. Med. J. 2001; 18: 494-5.
12. Manelli P, De Risio S, Pozzi G et al. Serendipitous rapid detoxification from opioids: The importance of time-dependent processes. Addiction 1999; 94: 589-91.
13. Bristow K, Meek R, Clark N. Acute opioid withdrawal in the emergency department: Inadvertent naltrexone abuse? Emerg. Med. 2001; 13: 359-63.
14. Thackway SV, Ward PL, Taylor LK. Active surveillance of adverse events associated with naltrexone in New South Wales. Med. J. Aust. 1999; 171: 499-500.
15. Murray P, Lintzeris N, Gijsbers A, Dunlop A. Guidelines for Prescribing for Drug Withdrawal. Turning Point Alcohol and Drug Centre, Fitzroy, Victoria, Melbourne, 2001.
16. Australian Institute of Health and Welfare (AIHW). 1998 National Drug Strategy Household Survey. Drug Statistics Series. AIHW, Canberra, 1999.